# Health Wildcatters

> Health Wildcatters is a VC fund in Dallas backing Health Care and Medical. See 104 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Dallas, United States
- Total investments: 104
- Last investment: Apr 2025
- Lead investor: 49%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/company/3113717
- X (Twitter): http://twitter.com/HWildCatters
- Website: http://healthwildcatters.com
- Facebook: http://www.facebook.com/HealthWildcatters

Health Wildcatters is a mentor-driven seed accelerator focused on improving healthcare by supporting entrepreneurs and healthcare startups. Healthcare IT, SaaS, digital health and mobile health companies are a fit, but they also encourage medical device, diagnostic and pharmaceutical companies to apply. What They Look For:Technology:Digital Health, mHealth, HealthIT, Medical Devices, Pharma, DiagnosticsCustomers: Hospitals, patients, doctors, anyone who could conceivably be a healthcare consumerLocation: Any company founders who will live in Dallas for the programFounders: Well-rounded founder teams >1 person, demonstrated understanding of entrepreneurship, relevant technical and business knowledgeCapital: Needing seed capital to support living expenses while bootstrapping, can make efficient use of limited capital, would generally be planning on self/angel/customer financing as a next step coming out of the program.

## Contacts

5 contacts available for Health Wildcatters. Shizune tracks 9 team members at Health Wildcatters. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/health-wildcatters?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 70 | 67% |
| Medical | 25 | 24% |
| Medical Device | 20 | 19% |
| Software | 15 | 14% |
| Biotechnology | 14 | 13% |

92 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 75 | 72% |
| Pre-Seed | 22 | 21% |
| Angel | 2 | 2% |
| Series B | 1 | 1% |
| Convertible Note | 1 | 1% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 87 | 84% |
| Israel | 4 | 4% |
| Italy | 1 | 1% |
| Spain | 1 | 1% |
| France | 1 | 1% |

9 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Akhil Reddy | Mentor | 0 | https://shizune.co/investors/profile/akhil-reddy-35dd |
| Carl Soderstrom | Co-founder & Partner | 1 | https://shizune.co/investors/profile/carl-soderstrom-2 |
| Clay Heighten | Co-founder & Partner | 2 | https://shizune.co/investors/profile/clay-heighten |
| Hubert Zajicek | Co-Founder, Partner & Chief Executive Officer | 29 | https://shizune.co/investors/profile/hubert-zajicek |
| Lindsey Settles | Program Manager | 0 | https://shizune.co/investors/profile/lindsey-settles |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| HarmonIQ Biosciences | HarmonIQ Biosciences offers AI-powered continuous hormone monitoring devices designed to deliver real-time, personalized insights into hormonal health. Services include data-driven tracking, early imbalance detection, and actionable recommendations to support wellness, performance, fertility planning, and long-term health management. | $30K | Seed | Apr 02, 2025 |  |
| Acute XR | Acute XR specializes in offering cutting-edge Virtual Reality treatment games that transport you to fascinating digital worlds and help you relax. | $30K | Pre-Seed | Sep 06, 2024 |  |
| Rhythmm AI | Rhythmm AI is transforming healthcare administration with its AI-powered prior permission software, which intelligently automates tedious paperwork, research, and approvals. | $30K | Pre-Seed | Sep 06, 2024 |  |
| TSP Therapeutics | TSP Therapeutics is a registration-stage oncology firm developing and commercializing histamine signaling therapeutics to be used in conjunction with immunotherapies to help save the lives of cancer patients who are resistant to immunotherapy. | $30K | Pre-Seed | Sep 06, 2024 |  |
| Delta Robotics | Delta Robotics is developing revolutionary Nitinol artificial muscle technology to transform the robotics and prosthetics industries. | $30K | Pre-Seed | Sep 06, 2024 |  |
| ClearSight Therapeutics | ClearSight Therapeutics is a biotech firm focusing on creating pharmaceutical and medical device solutions for ophthalmology. | $30K | Pre-Seed | Sep 06, 2024 |  |
| TeachMeNow | TeachMeNow is an AI-powered digital health product that transforms how patients understand their medical data. It focuses on serious issues in the healthcare industry, such as high readmission rates, rising expenditures, and the widespread problem of health illiteracy. | $30K | Pre-Seed | Sep 06, 2024 |  |
| MucoLife Therapeutics | MucoLife Therapeutics is transforming the therapeutic landscape for Chronic Obstructive Pulmonary Disorder (COPD) by creating first-in-class mucolytic medicines that target mucus congestion in the airways. | $30K | Pre-Seed | Sep 06, 2024 |  |
| Keyron | Keyron is a biomedical startup which produces medical devices for obesity, type 2 diabetes, and related comorbidities. | $30K | Seed | Sep 06, 2024 |  |
| Sensars | There are almost 5 millions of amputees, and even more nerve-injured persons, only in the USA and Europe. Together with commonly present neuropathic pain, and lost limb function (nerve injuries), they have no perception or control of the force required to hold or pick up objects and cannot feel their shape or consistency (when using prostheses). Acentury after the first prosthesis, electrodes, electronics and surgical expertise can be merged into the life-changing solution.Our venture is a synergistic effort converging expertise from microtechnologies, algorithms, electronics and clinical experimentation. We are an EPFL-based startup, founded by Francesco Petrini, Stanisa Raspopovic, and Silvestro Micera.Our mission is to re-enable upper, lower-limb amputees and nerve-damaged persons by:Restoring their complete sensory-motor functionality. Diminishing phantom limb pain. Enabling them to feel the artificial limb as part of their own body.From a market viewpoint, the nerve-injured persons do not have effective ways for function restoration, so we are proposing a novel tech and therefore generating a new market. As for amputees, the prosthetic limbs are getting more sophisticated but lack sensory feedback. We are constructing the game-changing functional improvement of the technology that will become the essential feature of the next-generation of prosthesis.Amputees and peripheral nerve damaged persons are in constant increase, mainly due to diabetes, car accidents, work injuries and wars. Among the most disabling consequences of these is the interruption of sensations flow from extremities to the brain. The absence of feedback and the perception of prosthesis as a foreign body are the primary reason for refusal to use prosthesis. Amputees cannot feel the shape or material of objects they are holding and have no perception of the force required to hold or pick up objects. Nerve-injured persons often have completely functionally unusable limbs. In 50-80% of cases, amputees and nerve-injured experience neuropathic pain from the missing part of the limb and drugs do not provide adequate relief. Providing them with an adequate sensory feedback would solve their problems. | $30K | Seed | Sep 06, 2024 |  |

10 of 104 investments shown.

## Co-investors
- [Green Park & Golf Ventures](https://shizune.co/investors/profile/green-park-golf-ventures) — VC Fund, 2 deals together
- [AngelMD](https://shizune.co/investors/profile/angel-md) — VC Fund, 1 deal together
- [Blossom Street Ventures](https://shizune.co/investors/profile/blossom-street-ventures) — VC Fund, 1 deal together
- [CH Innovations](https://shizune.co/investors/profile/ch-innovations) — VC Fund, 1 deal together
- [SOSV HAX](https://shizune.co/investors/profile/hax-accelerator) — VC Fund, 1 deal together
- [Illinois Ventures](https://shizune.co/investors/profile/illinois-ventures) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Health Wildcatters invest in?

Health Wildcatters invests primarily in Health Care, Medical and Medical Device startups, most often at Seed and Pre-Seed stage. Most of the 104 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Health Wildcatters?

Public channels for Health Wildcatters include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Health Wildcatters?

The team at Health Wildcatters includes Akhil Reddy (Mentor), Carl Soderstrom (Co-founder & Partner) and Clay Heighten (Co-founder & Partner), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co